宇邦新材(301266.SZ):擬將首發募投項目結項 並將節餘募資永久補充流動資金
格隆匯6月24日丨宇邦新材(301266.SZ)公佈,公司於2024年6月24日召開第四屆董事會第五次會議及第四屆監事會第三次會議,審議通過了《關於首次公開發行募投項目結項並將節餘募集資金永久補充流動資金的議案》,同意公司將首次公開發行股票募投項目結項,並將截至2024年6月21日的節餘募集資金共計9,125.85萬元(具體金額以資金轉出當日銀行結算餘額為準)永久補充流動資金,用於公司日常生產經營活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.